HomeStock MarketRakesh Jhunjhunwala stocks - Expert Recommendation investment 2022

Rakesh Jhunjhunwala stocks – Expert Recommendation investment 2022

Rakesh Jhunjunwala stock portfolio is skyrocketing. In the year 2020 net worth of Rakesh Jhunjhunwala was $2.7 Billion and today it is $5.8 Billion (43359 Cr – As on Feb 2022). This means jhunjhunwala net worth has grown more than twice last year. Year on year net worth analysis of Rakesh Jhunjhunwala is given below.

Rakesh Jhunjhunwala Net worth and stocks 2022

Big Bull Rakesh Jhunjhunwala is stock market king (Dalal street Raja) or Indian warren buffet who has made his fortune starting from Rs.5000 in the year 1985 and today he has made portfolio worth Rs.43359 Cr. His life journey is very interesting from a middle-class man to the topmost investor of India.

Rakesh Jhunjhunwala is a man with uncommon Intelligence. He is one of the most popular and respected equity investors of India. He manages his own equity portfolio as a partner in the asset management firm Rare Enterprises. 

Looking at the sky-touching net worth growth of Rakesh jhunjhunwala you must be excited to invest in RJ’s stock.

Here are 3 stocks from jhunjhunwala portfolio 2022 where experts are giving buy recommendations.

Rakesh Jhunjhunwala Stocks Expert Recommendation 

#1 Star Health Insurance

Star Health Insurance one of the star stocks in the portfolio of Big Bull Rakesh Jhunjhunwala, was listed in the Indian market on 10 December 2021. The listing of this stock was bad but after a few days buying was seen in the stock and stock has gone up to Rs 940 per share. As of Feb 2022, it is lifetime high for this stock.

This stock has been under constant pressure ever since touching its lifetime high and is currently approaching its 52-week low of Rs 715 per share. This stock has slipped 20% below its upper price band of Rs. 900. In such a situation, stock market experts from Religare Broking and GCL securities are advising to invest in Star Health Insurance for the long-term perspective. As per them, this stock can reach to level Rs.1100 or above in one year. With the decline in Covid cases, Star Health is expected to see strong growth in profit due to a reduction in provisioning. Therefore, it is expected that the company’s results will be very strong in the coming quarter.

#2 Federal Bank

Shares of Federal Bank, which is included in the portfolio of veteran investor Rakesh Jhunjhunwala, next buy recommendation by experts. Federal bank is trading at around 97 Rs per share as of Feb 2022.

Key product/revenue stream of a federal bank is Interest & Discount on Advances & Bills, Income From Investment, Interest On Balances with RBI, and Other Inter-Bank Funds. Recently the federal bank has also filed an IPO application at SEBI for Fedbank Financial Services Limited (FedFina).

HDFC Securities is bullish on the Federal bank and they are giving a buy recommendation with a target price of Rs.121. This investment rationale is based on growing profit margin and total asset growth.

#3 VA Tech Wabag

VA Tech Wabag is one of the very good stocks for the Rakesh Jhunjhunwala portfolio. VA Tech Wabag is Indian MNC focusing on water treatment for industrial users and municipalities.

VA Tech Wabag is recommended stock by Nomura and ICICI Securities. ICICI Securities said that even in this situation, the company’s operating margin has improved despite the increase in the cost of production due to better fulfillment of industrial and overseas orders. Considering the company’s strong performance in the 9 months of FY 2022 and strong order book, ICICI Securities has given buy recommendation on VA Tech’s in 2022 with a target of Rs 365 to Rs 366.

Over to you

Do you hold any of the Rakesh Jhunjhunwala stocks given above? What is your comment on the expert recommendation on Jhuhjhunwala’s stock?

Shitanshu Kapadia
Shitanshu Kapadia
Hi, I am Shitanshu founder of I am engaged in blogging & Digital Marketing for 10 years. The purpose of this blog is to share my experience, knowledge and help people in managing money. Please note that the views expressed on this Blog are clarifications meant for reference and guidance of the readers to explore further on the topics. These should not be construed as investment , tax, financial advice or legal opinion. Please consult a qualified financial planner and do your own due diligence before making any investment decision.